Showing 541 - 560 results of 20,751 for search '(( 5 ((ng decrease) OR (teer decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 0.67s Refine Results
  1. 541

    Image 1_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  2. 542

    Table 1_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.docx by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  3. 543

    Image 4_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  4. 544

    Image 2_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  5. 545

    Image 3_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  6. 546
  7. 547

    SMNΔ7 NMJs display a decrease in synaptic efficacy. by Karen K. Y. Ling (237660)

    Published 2010
    “…There is an increase in MEPP amplitude, a decrease in MEPP frequency and a reduction in quantal content in SMNΔ7 mice (n = 100–130 NMJs from 7 control and 10 SMNΔ7 mice; ***<i>p</i><0.0001, ** <i>p</i> = 0.007). …”
  8. 548
  9. 549
  10. 550
  11. 551
  12. 552

    GBE decreased secretion of Aβ1-40 in APP cells. by Virginie Rhein (243241)

    Published 2010
    “…Secreted Aβ1-40 was significantly decreased in GBE-treated APP cells (100 µg/ml; 24 h). …”
  13. 553
  14. 554
  15. 555
  16. 556

    Decreased mitochondrial reactive oxygen species in Aβ resistant cells. by Jordan T. Newington (223389)

    Published 2011
    “…This decrease in ROS was maintained with 48 hr Aβ (20 µM) exposure. …”
  17. 557

    Inhibition of PSMA decreases pathologic angiogenesis in a mouse model of OIR. by Christina L. Grant (315488)

    Published 2013
    “…<p><b>A</b>) Wild type mice undergoing OIR were treated systemically with either a single dose of 100mg/kg 2-PMPA on P14 (n = 3, <b>center</b>) or three daily doses from P14 through P16 (n = 6, <b>right</b>), controls received vehicle (PBS, <b>left</b>). …”
  18. 558

    Phosphopeptides with predicted MAPK site that showed decreased abundance in 1NM-PP1-treated <i>mak-2<sup>Q100G</sup></i> cells. by Wilfried Jonkers (160931)

    Published 2014
    “…</p>3<p>Showed reduced expression in a <i>mak-2<sup>Q100G</sup></i> germlings treated with 1NM-PP1 (19).…”
  19. 559
  20. 560